Subcutaneous Tirzepatide for Type 2 Diabetes, Noninvasive Respiratory Strategies for COVID-19 and Acute Hypoxemic Respiratory Failure, Clinical Outcomes 1 Year After ICU Treatment for COVID-19, and more
Editor's Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the February 8, 2022 issue.
Source: JAMA: This Week's Audio Commentary - Category: General Medicine Authors: JAMA Network Source Type: podcasts
More News: American Medical Association (AMA) | COVID-19 | Diabetes | Diabetes Type 2 | Endocrinology | General Medicine | Respiratory Medicine